Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 26, 2025 | (Q2)Jun 27, 2025 | (Q1)Mar 28, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 27, 2024 | (Q2)Jun 27, 2024 | (Q1)Mar 29, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 500.56%5.04B | 6.30%3.81B | -1,085.23%-5.2B | -41.33%6.81B | 47.98%3.95B | -129.28%-1.26B | -19.78%3.59B | 230.00%528M | 5.27%11.6B | -9.49%2.67B |
| Net income from continuing operations | 29.23%3.68B | 58.39%3.8B | 4.71%3.34B | -0.50%10.65B | 11.43%2.21B | -7.56%2.85B | -4.76%2.4B | 2.31%3.19B | 11.83%10.7B | -3.40%1.99B |
| Operating gains losses | -16.03%-456M | 80.63%-62M | -421.95%-214M | -8.06%-912M | -221.54%-158M | 27.36%-393M | -53.11%-320M | 81.70%-41M | -32.91%-844M | 395.45%130M |
| Depreciation and amortization | 0.00%268M | 3.72%279M | 1.91%267M | -4.70%1.08B | 1.85%276M | -7.59%268M | -4.27%269M | -8.39%262M | -10.48%1.13B | -11.73%271M |
| Remuneration paid in stock | 10.45%74M | -6.94%67M | -7.35%63M | 12.60%286M | 2.60%79M | 17.54%67M | 16.13%72M | 17.24%68M | -28.65%254M | -7.23%77M |
| Deferred tax | -81.68%37M | 1,355.17%364M | 154.91%95M | -450.00%-11M | -107.24%-11M | 254.39%202M | 93.84%-29M | -166.54%-173M | 98.36%-2M | 1,069.23%152M |
| Other non cashItems | -59.41%246M | -94.74%70M | -415.28%-227M | 61.86%1.95B | -283.87%-57M | 29.76%606M | 14.35%1.33B | 115.79%72M | 1.09%1.21B | 126.05%31M |
| Change In working capital | 124.51%1.19B | -410.79%-710M | -199.51%-8.52B | -636.88%-6.23B | 6,895.65%1.61B | -647.80%-4.86B | -112.40%-139M | 1.11%-2.85B | -39.83%-846M | -96.48%23M |
| -Change in receivables | ---- | ---- | ---- | -14,650.00%-295M | ---- | ---- | ---- | ---- | 97.10%-2M | ---- |
| -Change in inventory | ---- | ---- | ---- | 12.90%-520M | ---- | ---- | ---- | ---- | 37.81%-597M | ---- |
| -Change in prepaid assets | ---- | ---- | ---- | -1,654.49%-5.67B | ---- | ---- | ---- | ---- | -243.56%-323M | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | 18.25%311M | ---- | ---- | ---- | ---- | -34.09%263M | ---- |
| -Change in other current liabilities | ---- | ---- | ---- | 66.31%-63M | ---- | ---- | ---- | ---- | 6.50%-187M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 500.56%5.04B | 6.30%3.81B | -1,085.23%-5.2B | -41.33%6.81B | 47.98%3.95B | -129.28%-1.26B | -19.78%3.59B | 230.00%528M | 5.27%11.6B | -9.49%2.67B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -45.67%1.26B | 18.29%789M | -423.33%-1.07B | 175.37%2.52B | 15.44%-783M | 239.41%2.31B | 175.54%667M | 182.05%330M | -338.93%-3.35B | -164.94%-926M |
| Net PPE purchase and sale | -3.06%-471M | -5.30%-437M | 15.45%-301M | -13.84%-2.02B | 3.28%-796M | -20.90%-457M | -28.88%-415M | -39.61%-356M | -26.19%-1.78B | -21.21%-823M |
| Net business purchase and sale | -130.02%-130M | 3,033.33%88M | -75.53%706M | 761.41%3.17B | -268.60%-145M | 8,560.00%433M | 86.36%-3M | 864.88%2.89B | -4.42%368M | -56.12%86M |
| Net investment purchase and sale | -11.63%1.67B | -11.13%838M | 28.75%-1.5B | 140.49%949M | 134.26%222M | 257.54%1.89B | 265.15%943M | -2,873.68%-2.11B | -329.80%-2.34B | -156.84%-648M |
| Net other investing changes | -58.37%184M | 111.27%300M | 132.97%30M | 5.93%429M | -113.94%-64M | 632.53%442M | 343.75%142M | -2,933.33%-91M | 153.36%405M | -40.31%459M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -45.67%1.26B | 18.29%789M | -423.33%-1.07B | 175.37%2.52B | 15.44%-783M | 239.41%2.31B | 175.54%667M | 182.05%330M | -338.93%-3.35B | -164.94%-926M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -251.23%-3.14B | -260.34%-3.38B | 745.32%3.43B | 16.85%-6.91B | -29.80%-5.48B | 71.04%-894M | 69.38%-938M | -80.34%406M | 18.93%-8.31B | 18.31%-4.23B |
| Net issuance payments of debt | -257.02%-2B | -197.29%-1.15B | 317.52%3.84B | 36.13%2.53B | -232.45%-845M | 221.08%1.28B | 287.74%1.18B | -68.31%919M | 293.84%1.86B | 141.21%638M |
| Net common stock issuance | -105.41%-152M | -52.00%-38M | 48.79%-211M | 40.11%-1.05B | 45.26%-537M | -68.18%-74M | 76.42%-25M | 33.44%-412M | -201.20%-1.75B | -891.13%-981M |
| Cash dividends paid | -0.86%-2.11B | -5.23%-2.19B | 10.10%-89M | -5.12%-8.36B | -5.45%-4.09B | -5.08%-2.09B | -4.88%-2.09B | 1.98%-99M | -4.41%-7.95B | -4.53%-3.87B |
| Net other financing activities | 22,540.00%1.12B | 85.71%-1M | -5,150.00%-105M | 93.33%-31M | -112.50%-17M | -400.00%-5M | 97.95%-7M | 98.26%-2M | 57.53%-465M | 80.95%-8M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -251.23%-3.14B | -260.34%-3.38B | 745.32%3.43B | 16.85%-6.91B | -29.80%-5.48B | 71.04%-894M | 69.38%-938M | -80.34%406M | 18.93%-8.31B | 18.31%-4.23B |
| Net cash flow | ||||||||||
| Beginning cash position | -26.67%10.2B | -19.40%8.42B | 18.53%11.49B | -1.35%9.69B | 15.98%14.16B | 8.26%13.91B | -13.00%10.44B | -1.35%9.69B | -2.00%9.83B | 17.02%12.21B |
| Current changes in cash | 1,911.46%3.16B | -63.19%1.22B | -324.45%-2.84B | 4,131.67%2.42B | 6.65%-2.32B | 135.36%157M | 533.65%3.31B | -46.03%1.26B | -1,300.00%-60M | -211.68%-2.48B |
| Effect of exchange rate changes | -96.70%3M | 177.17%169M | 218.12%163M | -753.42%-623M | -864.86%-357M | 145.96%91M | -546.94%-219M | -222.12%-138M | 64.39%-73M | -119.79%-37M |
| Cash adjustments other than cash changes | ---- | ---- | -5.87%-397M | ---- | ---- | ---- | ---- | -35.87%-375M | ---- | ---- |
| End cash Position | -5.63%13.36B | -26.67%10.2B | -19.40%8.42B | 18.53%11.49B | 18.53%11.49B | 15.98%14.16B | 8.26%13.91B | -13.00%10.44B | -1.35%9.69B | -1.35%9.69B |
| Free cash from | 364.12%4.56B | 6.51%3.37B | -3,587.97%-5.51B | -51.36%4.74B | 73.06%3.15B | -144.15%-1.73B | -23.41%3.16B | 236.21%158M | 2.23%9.75B | -18.87%1.82B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.